Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New surgical technique aims to restore hand pinch after nerve injury

NCT ID NCT07434999

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a surgical procedure that moves two tendons in the forearm to help people with long-term ulnar nerve damage regain the ability to pinch. 17 adults aged 18-60 with stable joints and no other nerve injuries will be followed for 12 weeks after surgery. The goal is to see if grip strength and hand function improve.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Combined ECRB and APL tendon transfer surgery
What this could lead to
If successful, this surgical technique could improve hand function and daily activities for people with chronic ulnar nerve injury.
What could go wrong
This is a very small study (17 people) with no comparison group, so results may not apply widely. Surgery carries risks like infection or limited improvement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 17 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with chronic ulnar nerve injury (more than 1 year duration). * Age between 18 and 60 years. * Patients with stable joints and good passive range of motion of the hand and fingers. * Absence of active infection or severe contracture. Exclusion Criteria: * • Patients with combined median or radial nerve injury. * Patients with severe soft-tissue loss or fixed deformities precluding tendon transfer. * Uncooperative patients or those with systemic diseases affecting muscle power or healing (e.g., diabetes mellitus, peripheral vascular disease).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic ulnar nerve injury are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • SohagUniversity

    Sohag, Egypt